Medpace (MEDP) Surged Following Better-Than-Expected Results

Madison Investments, an investment advisor, released its “Madison Mid Cap Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. In the third quarter, the fund (Class I) returned 1.9% compared to the 5.3% increase for the Russell Midcap Index. The Russell Mid Cap Index experienced significant growth in the third quarter of 2025. Information Technology led the performance both in the quarter and YTD. In addition, please check the fund’s top five holdings to know its best picks in 2025.

In its third-quarter 2025 investor letter, Madison Mid Cap Fund highlighted stocks such as Medpace Holdings, Inc. (NASDAQ:MEDP). Medpace Holdings, Inc. (NASDAQ:MEDP) is a clinical research-based drug and medical device development services provider. The one-month return of Medpace Holdings, Inc. (NASDAQ:MEDP) was -3.15%, and its shares gained 73.55% of their value over the last 52 weeks. On November 20, 2025, Medpace Holdings, Inc. (NASDAQ:MEDP) stock closed at $586.16 per share, with a market capitalization of $17.047 billion.

Madison Mid Cap Fund stated the following regarding Medpace Holdings, Inc. (NASDAQ:MEDP) in its third quarter 2025 investor letter:

"The top five contributors for the quarter were Medpace Holdings, Inc. (NASDAQ:MEDP), Amphenol, Arista Networks, MKS, and Ross Stores. Shares in Medpace jumped following much better-than-expected 2Q results. Investors were expecting growth to continue to slow for the contract research industry, but instead, Medpace posted accelerating 2Q revenue and bookings growth, and expressed confidence in the trends continuing for the rest of the year."

Medpace Holdings, Inc. (NASDAQ:MEDP) is not on our list of 30 Most Popular Stocks Among Hedge Funds. According to our database, 42 hedge fund portfolios held Medpace Holdings, Inc. (NASDAQ:MEDP) at the end of the second quarter, the same as in the previous quarter. Medpace Holdings, Inc. (NASDAQ:MEDP) reported revenue of $659.9 million in the third quarter 2025, representing an increase of 23.7% year-over-year. While we acknowledge the potential of Medpace Holdings, Inc. (NASDAQ:MEDP) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

In another article, we covered Medpace Holdings, Inc. (NASDAQ:MEDP) and shared Optimist Fund's views on the company. In addition, please check out our hedge fund investor letters Q3 2025 page for more investor letters from hedge funds and other leading investors.

READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.

Disclosure: None. This article is originally published at Insider Monkey.